Proteomic and phosphoproteomic characteristics of the cortex . . . Methods: In this study, we performed liquid chromatography-mass spectrometry-based proteomic and phosphoproteomic analyses of the cortex, hippocampus, thalamus, lungs, and kidneys of SARS-CoV-2-infected K18-hACE2 female mice
Proteomic and phosphoproteomic characteristics of the cortex . . . In this study, we performed proteomic and phosphoproteomic analyses of the cortex, hippocampus, thalamus, lung, and kidney of COVID-19-infected K18- hACE2 mice, providing cerebral proteomic datasets related to COVID-19 in vivo
Proteomic and phosphoproteomic characteristics of the . . . This study provides observations and in vivo datasets for COVID-19-associated proteomic and phosphoproteomic alterations in multiple organs, especially cerebral tissues, of K18- hACE2 mice
Proteomic and phosphoproteomic characteristics of the cortex . . . Observations and in vivo datasets for COVID-19-associated proteomic and phosphoproteomic alterations in multiple organs, especially cerebral tissues, of K18-hACE2 mice can be used as baits to identify candidate therapeutic drugs for COVID-19
Proteomic and phosphoproteomic characteristics of the cortex . . . INTERPRETATION: This study provides observations and in vivo datasets for COVID-19-associated proteomic and phosphoproteomic alterations in multiple organs, especially cerebral tissues, of K18-hACE2 mice
COVID-19 感染的 K18-hACE2 雌性小鼠大脑皮层、海马体 . . . This study provides observations and in vivo datasets for COVID-19-associated proteomic and phosphoproteomic alterations in multiple organs, especially cerebral tissues, of K18-hACE2 mice
Proteomic and phosphoproteomic characteristics of the cortex . . . In this study, we performed proteomic and phosphoproteomic analyses of the cortex, hippocampus, thalamus, lung, and kidney of COVID-19-infected K18- hACE2 mice, providing cerebral proteomic datasets related to COVID-19 in vivo
Proteomic and phosphoproteomic characteristics of the cortex . . . Observations and in vivo datasets for COVID-19-associated proteomic and phosphoproteomic alterations in multiple organs, especially cerebral tissues, of K18-hACE2 mice can be used as baits to identify candidate therapeutic drugs for COVID-19
Proteomic and phosphoproteomic characteristics of the cortex . . . In this study, we performed proteomic and phosphoproteomic analyses of the cortex, hippocampus, thalamus, lung, and kidney of COVID-19-infected K18- hACE2 mice, providing cerebral proteomic datasets related to COVID-19 in vivo